Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Neurointerventional Devices Market — Insights

Neurointervention offers minimally invasive treatment for disorders of the blood vessels in the brain and the spine. It is less invasive compared to other conventional modes of treatment and offers shorter recovery time, fewer complications, and less pain after a procedure is done.

The global neurointerventional devices market is estimated to account for US$ 3,104.8 Mn in terms of value by the end of 2027.

Global Neurointerventional Devices Market: Drivers

Increasing prevalence of brain aneurysm is expected to boost growth of the global neurointerventional devices market over the forecast period. For instance, according to Cerebral Aneurysms Fact Sheet, National Institute of Neurological Disorders and Stroke (NINDS), May 2018, around 30,000 people in the U.S. suffer a brain aneurysm rupture, annually.

Moreover, increasing cases of Traumatic Brain Injuries (TBI) is also expected to propel growth of the market. For instance, according to the study, ‘Estimating the Global Incidence of Traumatic Brain Injury’ published in the Journal of Neurosurgery in April 2019, 69 million people worldwide are estimated to suffer TBI from all causes, annually.

North America region held dominant position in the global neurointerventional devices market in 2018, accounting for 40.7% share in terms of value, followed by Asia Pacific.

Figure 1. Global Neurointerventional Devices Market Value (US$ Mn), by Region, 2018

Neurointerventional Devices  | Coherent Market Insights

Global Neurointerventional Devices Market: Restraints

High costs of neurointerventional devices is a major factor hindering growth of the global neurointerventional devices market. For instance, average cost of a neurointerventional device is US$ 1,000.

Moreover, some of the recently introduced devices have been severely criticised for their performance, which has led to strong backslash from physicians and other industry experts. Such scenario is also expected to hamper the market growth.

Global Neurointerventional Devices Market: Opportunities

Embolic Coils segment in the global neurointerventional devices market was valued at US$ 730.3 Mn in 2018 and is expected to reach US$ 1,044.4 Mn by 2027 at a CAGR of 4.1% during the forecast period.

Market Trends/Key Takeaways

Key players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in October 2019, Siemens Healthineers AG completed the acquisition of Corindus Vascular Robotics, Inc., a provider of robotic assisted minimally invasive procedures.

The market is witnessing increasing use of human robotic-assisted neurovascular intervention for the treatment of neurological disorders. For instance, in November 2019, Corindus, a Siemens Healthineers Company, announced that its CorPath GRX System was used to complete the first-in-human robotic-assisted neurovascular intervention.

Regulations

In the U.S., Center for Devices and Radiological Health (CDRH) reviews each medical device submission and the level of regulatory control for an individual device is based on a risk-based approach. CDRH classifies a device as Class I, II, or III.

In 2016, the U.S. Food and Drug Administration created a new regulation (21 CFR 882.5600, Neurovascular Mechanical Thrombectomy Device for Acute Ischemic Stroke Treatment, product code POL) and associated special controls.

Global Neurointerventional Devices Market: Competitive Landscape

Major players operating in the global neurointerventional devices market include, Stryker Corporation, Penumbra Inc., Medtronic, Johnson & Johnson Private Limited, Imperative Care, Inc., Anaconda Biomed S.L., Insera Therapeutics, Inc., Perflow Medical, and Terumo Corporation.

Global Neurointerventional Devices Market: Key Developments

Key players in the market are focused on raising funds to expand their product portfolio. For instance, in December 2019, Imperative Care, Inc. completed the initial closing of a Series C financing of US$ 85 million to support the commercial launch of the company’s portfolio that includes latest advances in neurovascular devices used for the treatment of ischemic and hemorrhagic strokes.

Key players in the market are also focused on R&D to expand their product portfolio. For instance, in September 2019, Medtronic plc. announced that the National Osteoporosis Foundation (NOF) supports the VCF Care Pathway, a new evidence-based clinical care pathway developed by a multispecialty panel of experts to ensure osteoporotic vertebral compression fracture (VCF) patients receive timely and appropriate care.

Neurointerventional Devices offers minimally invasive therapies for lesions of the head, neck, spine, brain, and spinal cord used for reopening of blocked normal vessels. Nonvascular interventions comprises of percutaneous vertebral augmentation procedures, pain management, percutaneous biopsies, and percutaneous management of disk disease. Increasing incidence of stroke is anticipated to increase demand for neurointerventional devices.

Key features of the study:

  • This report provides in-depth analysis of the Neurointerventional Devices market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Neurointerventional Devices market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Stryker Corporation, Penumbra Inc., Medtronic, Johnson & Johnson Private Limited, Imperative Care, Inc., Anaconda Biomed S.L., Insera Therapeutics, Inc., Perflow Medical, and Terumo Corporation.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Neurointerventional Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Neurointerventional Devices market

Detailed Segmentation:

  • Neurointerventional Devices Market, By Product Type:
    • Embolic Coils
    • Carotid Stents
    • Intracranial Stents
    • Neurovascular Thrombectomy
    • Embolic Protection Devices
    • Flow Diverters Devices
    • Intrasaccular Devices
    • Liquid Embolic
    • Balloons
    • Stent Retrievers
  •  Neurointerventional Devices Market, By End User:
    • Hospitals
    • Clinics
  • Neurointerventional Devices Market, By Technique:
    • Neurothrombectomy Procedure
    • Cerebral Angiography
    • Stenting
    • Coiling Procedures
    • Flow Disruption
  • Neurointerventional Devices Market, By Region:
    • North America
      • By Product Type:
        • Embolic Coils
        • Carotid Stents
        • Intracranial Stents
        • Neurovascular Thrombectomy
        • Embolic Protection Devices
        • Flow Diverters Devices
        • Intrasaccular Devices
        • Liquid Embolic
        • Balloons
        • Stent Retrievers
      • By End User
        • Hospitals
        • Clinics
      • By Technique
        • Neurothrombectomy Procedure
        • Cerebral Angiography
        • Stenting
        • Coiling Procedures
        • Flow Disruption
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Embolic Coils
        • Carotid Stents
        • Intracranial Stents
        • Neurovascular Thrombectomy
        • Embolic Protection Devices
        • Flow Diverters Devices
        • Intrasaccular Devices
        • Liquid Embolic
        • Balloons
        • Stent Retrievers
      • By End User
        • Hospitals
        • Clinics
      • By Technique
        • Neurothrombectomy Procedure
        • Cerebral Angiography
        • Stenting
        • Coiling Procedures
        • Flow Disruption
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Embolic Coils
        • Carotid Stents
        • Intracranial Stents
        • Neurovascular Thrombectomy
        • Embolic Protection Devices
        • Flow Diverters Devices
        • Intrasaccular Devices
        • Liquid Embolic
        • Balloons
        • Stent Retrievers
      • By End User
        • Hospitals
        • Clinics
      • By Technique
        • Neurothrombectomy Procedure
        • Cerebral Angiography
        • Stenting
        • Coiling Procedures
        • Flow Disruption
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Embolic Coils
        • Carotid Stents
        • Intracranial Stents
        • Neurovascular Thrombectomy
        • Embolic Protection Devices
        • Flow Diverters Devices
        • Intrasaccular Devices
        • Liquid Embolic
        • Balloons
        • Stent Retrievers
      • By End User
        • Hospitals
        • Clinics
      • By Technique
        • Neurothrombectomy Procedure
        • Cerebral Angiography
        • Stenting
        • Coiling Procedures
        • Flow Disruption
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Embolic Coils
        • Carotid Stents
        • Intracranial Stents
        • Neurovascular Thrombectomy
        • Embolic Protection Devices
        • Flow Diverters Devices
        • Intrasaccular Devices
        • Liquid Embolic
        • Balloons
        • Stent Retrievers
      • By End User
        • Hospitals
        • Clinics
      • By Technique
        • Neurothrombectomy Procedure
        • Cerebral Angiography
        • Stenting
        • Coiling Procedures
        • Flow Disruption
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Embolic Coils
        • Carotid Stents
        • Intracranial Stents
        • Neurovascular Thrombectomy
        • Embolic Protection Devices
        • Flow Diverters Devices
        • Intrasaccular Devices
        • Liquid Embolic
        • Balloons
        • Stent Retrievers
      • By End User
        • Hospitals
        • Clinics
      • By Technique
        • Neurothrombectomy Procedure
        • Cerebral Angiography
        • Stenting
        • Coiling Procedures
        • Flow Disruption
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Stryker Corporation, Penumbra Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Medtronic
    • Johnson & Johnson Private Limited
    • Imperative Care Inc.
    • Anaconda Biomed S.L
    • Insera Therapeutics, Inc.
    • Perflow Medical
    • Terumo Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By End User
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Technological Advancements
    • Key Highlights
    • Product launch
    • Regulatory Scenario
    • PEST Analysis
    • Mergers and Acquisitions
  4. Global Neurointerventional Devices Market, By Product Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Embolic Coils
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Carotid Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Intracranial Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Neurovascular Thrombectomy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Embolic Protection Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Flow Diverters Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Intrasaccular Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Liquid Embolic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Balloons
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Stent Retrievers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  5. Global Neurointerventional Devices Market, By End User, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  6. Global Neurointerventional Devices Market, By Technique, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Neurothrombectomy Procedure
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Cerebral Angiography
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Stenting
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Coiling Procedures
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Flow Disruption
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  7. Global Neurointerventional Devices Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Company Profiles
      • Stryker Corporation, Penumbra Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Johnson & Johnson Private Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Imperative Care Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Anaconda Biomed S.L
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Insera Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Perflow Medical
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Terumo Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 34 figures on “Neurointerventional Devices Market - Global forecast to 2027”.

Frequently Asked Questions

The global neurointerventional devices market is estimated to reach US$ 3,104.8 Mn, in terms of value by the end of 2027.
Major players operating in the global neurointerventional devices market include Stryker Corporation, Penumbra Inc., Medtronic, Johnson & Johnson Private Limited, Imperative Care, Inc., Anaconda Biomed S.L., Insera Therapeutics, Inc., Perflow Medical, and Terumo Corporation.
High cost of neurointerventional devices is one of the major factors that is expected to hamper growth of the market over the forecast period.
Increasing prevalence of brain aneurysm is one of the major factors that is expected to propel growth of the market over the forecast period.
Increasing product approval activities is one of the major trends that has been observed in the market.
Among regions, North America held a dominant position in the global neurointerventional devices market in 2018, accounting for 40.7% share in terms of value, followed by Asia Pacific.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner